ValnevaSE announced the appointment of Dipal Patel as chief commercial officer (CCO) and management board member. With this newly created role, Valneva strengthens its management team with a recognized commercial industry leader as the company advances its chikungunya vaccine candidate towards potential market entry in 2023. Ms. Patel is an established commercial leader with over 23 years of experience in the pharmaceutical sector covering commercial strategy, execution, market access and lifecycle management.

Over her career, she has held roles of increasing responsibilities across multiple countries including the United States, Australia, Belgium, Singapore, Thailand, and the European and emerging markets regions. Since 2019, Ms. Patel has been Global Commercial Head of GSK's shingles vaccine.